Out of business. Please don't do any further orders.

Audio Seminars

Home | Contact Us | Newsletter | Usersclub | Books | Audio Seminars

All documents shown here are included in the seminar for instant download - and more

1. How much can you change an official methods before it isn't the official method any more 

2. Analytical method validation - A Regulatory Perspective

Verification of Compendial Procedures

Learn from FDA Warning Letters what inspectors look for and what mistakes other companies make so you can avoid them

Labcompliance On-line Audio Seminar

This seminar has been recorded and is available on CD and for instant download. All reference material as listed below and more is available on a special seminar website. The website is regularly updated with most recent information. In case there are questions related to the topic, they can be submitted through a web form and will be answered by the speaker. For ordering info click here.

On-line Audio Seminar 176

Transfer of Analytical Methods and Procedures

FDA Requirements, Strategies and Tools for Implementation


Order Button

When validated methods are transferred between laboratories and sites, their validated state should be maintained to ensure the same reliable results in the receiving laboratory. Until recently there was specific FDA guidance on what exactly is expected to maintain 'the validated state'. Now the FDA has released an official guidance on how to conduct and document method transfer. The guide has been developed for medicated feed assays but the principles can be applied to other methods. The guide answers questions managers and lab analysts had on what to do and how to conduct and document method transfer.

Key Questions are:

  • Method transfer is easy, why should we go through a formal process?
  • Are there any specific FDA requirements?
  • Should the receiving laboratory do full revalidation?
  • What should be tested in the receiving laboratory?
  • What can go wrong during method transfer?
  • Anything to care about for transfer to other sites?
  • Are system suitability tests sufficient?
  • How much can I change a transferred method without revalidation?
  • When can 'official' method transfer be omitted?
  • What are the responsibilities of the transferring and receiving laboratories
  • How should we 'formally' document method transfer?

How does the this audio seminar help:

Answers will be presented by Dr. Ludwig Huber in a new interactive audio seminar. During the seminar, the speaker will present strategies and give practical recommendations. After the seminar, an extensive list of reference material like SOPs and checklist will help immediate and cost effective implementation.

During the interactive presentation you learn about:

  • FDA and International regulations for method transfer
  • Examples of FDA warning letters and how to avoid them
  • The new FDA Guidance on method transfer.
  • Developing a strategy for analytical method transfer
  • Developing an SOP for method transfer
  • Responsibilities of the transferring and receiving laboratory
  • Developing a transfer plan: contents and approval
  • Method transfer options
  • Types of method transfer and testing
  • The importance of acceptance criteria
  • Conducting comparative studies
  • Statistical evaluating transfer results
  • Most likely failures during method transfer
  • Criteria for transfer waiver (omission of formal transfer)
  • Method transfer protocol and summary report

And for easy and instant implementation:
download 10+ documents from special seminar website

  • Master Plan: - Transfer of Analytical Methods and procedures
  • SOPs
    - Verification of Compendial Methods
    - Transfer of Analytical Methods
  • Templates/Checklist:
    - Validation of Analytical Methods and Procedures
    - Laboratory Audits
  • Reference Articles
    - Validation of Analytical Methods: Review and Strategy
    - Evaluation and Validation of Standard Methods
    - Adjusting Conditions for a Routine Reversed-Phase HPLC Assay,
    Part II: Changing Separation Conditions (link)
  • Five Warning letters and/or Inspectional observations related to method validation
  • FDA Guidance and Policy:
    - Analytical Procedures and Methods Validation
  • FDA Industry Guidance: Protocol for the Conduct of Method Transfer for Type C Medicated Feed Assay Methods
  • FDA presentations on method validation
    - How Much Can You Change An Official Method Before It Isn‘t The Official Method Anymore?
    - Analytical Methods Validation, A Regulatory Perspective
  • ICH Guidelines for the Industry
    - Text on Validation of Analytical Procedures
    - Validation of Analytical Procedures: Methodology

Who should attend?

  • Everybody involved in method transfer
  • QA managers and personnel
  • Analysts and lab managers
  • Validation specialists
  • Training departments
  • Documentation department
  • Consultants

How to order

Replaced by the more recent seminar

Transfer of Analytical Procedures According to the New USP Chapter <1224>

With SOPs, templates and examples for easy implementation

Click here

About audio seminars


Online audio seminars are presented over the phone. During the live presentation attendees can:

  1. Study the printed slide material
  2. Watch the slides on a computer
  3. Watch the slides on a video screen in a seminar room
  4. Ask questions through email and web form

About Dr. Ludwig Huber

Dr. Ludwig Huber is the editor and author of Labcompliance. He has been conducting over 300 web and audio or video based seminars since 15 years and and he has given multiple presentations mainly on GLP/GMP, 21 CFR Part 11 and Validation around the world. This included seminars, workshops and presentations for the US FDA, SFDA, KFDA, HSA, ISPE, PDA, PIC/S and several national health agencies.

Dr. Ludwig Huber is a frequent presenter at IVT conferences and has been awarded as the 'Presenter of the Year' out of 170 speakers. This photo is from IVT's conference on Network Qualification with Ludwig Huber as plenary speaker.

Dr. Huber has published several books related to validation and compliance, for example: Validation of Computerized Analytical and Networked Systems. He was or still is a member of several committees, e.g., of the GAMP® Special interest group (SIG) on Laboratory Computers, PDA Part 11 task force, IVT task force on network infrastructure qualification and the European Compliance Academy. He frequently visited FDA in Rockville, VA, and participated in panel discussions with FDA professionals. For feedback from attendees of seminars and  for other information on Dr. Ludwig Huber, click here.